- Novozymes A/S 2024 Outlook and 2023 Pro Forma Financials Call TranscriptMar 21, 2024
- Novozymes A/S Extraordinary Shareholders Meeting TranscriptMar 04, 2024
- Q4 2023 Novozymes A/S Earnings Call TranscriptFeb 01, 2024$53.11 (+3.35%)Earnings
- Q3 2023 Novozymes A/S Earnings Call TranscriptOct 26, 2023$42 (+8.11%)Earnings
- Q2 2023 Novozymes A/S Earnings Call TranscriptAug 09, 2023$48.92Earnings
- Q1 2023 Novozymes A/S Earnings Call TranscriptApr 26, 2023$53.25 (-3.43%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 02, 2023
- Q4 2022 Novozymes A/S Earnings Call TranscriptJan 26, 2023$50.86 (+0.48%)Earnings
- Novozymes A/S and Chr Hansen Holding A/S to Discuss Agreement to Combine Through a Statutory Merger Call TranscriptDec 12, 2022
- Q3 2022 Novozymes A/S Earnings Call TranscriptNov 03, 2022$50.49 (-1.67%)Earnings
- Q2 2022 Novozymes A/S Earnings Call TranscriptAug 11, 2022$59.31Earnings
- Novozymes A/S Spotlight on Human Health Presentation TranscriptJun 17, 2022
- Q1 2022 Novozymes A/S Earnings Call TranscriptApr 27, 2022$67.68 (-0.75%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 16, 2022
- Q4 2021 Novozymes A/S Earnings Call TranscriptFeb 01, 2022$65.7 (-6.06%)Earnings
- Q3 2021 Novozymes A/S Earnings Call TranscriptOct 27, 2021$72.38 (-0.51%)Earnings
- Novozymes A/S Capital Markets Day (Virtual) TranscriptSep 28, 2021
- Q2 2021 Novozymes A/S Earnings and to Discuss Investment Into Advanced Protein Solutions Call TranscriptAug 12, 2021
- Q1 2021 Novozymes A/S Earnings Call TranscriptApr 27, 2021$73.5 (+8.13%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 11, 2021
- Q4 2020 Novozymes A/S Earnings Call TranscriptFeb 02, 2021$60.52 (-0.13%)Earnings
- Q3 2020 Novozymes A/S Earnings Call TranscriptOct 21, 2020$63.63 (-2.48%)Earnings
- Q2 2020 Novozymes A/S Earnings Call TranscriptAug 12, 2020$60.42Earnings
- Q2 2020 Novozymes A/S Trading Update Call TranscriptJul 08, 2020
- Q1 2020 Novozymes A/S Earnings Call TranscriptApr 29, 2020$48.9 (+4.40%)Earnings
- Q1 2020 Novozymes A/S Organic Sales Call TranscriptApr 07, 2020
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 26, 2020
- Q4 2019 Novozymes A/S Earnings Call TranscriptJan 23, 2020$51.26 (+5.24%)Earnings
- Q3 2019 Novozymes A/S Earnings Call TranscriptOct 23, 2019$45 (+4.14%)Earnings
- Novozymes A/S to Discuss the Adjusted FY 2019 Outlook Call TranscriptOct 10, 2019
- Q2 2019 Novozymes A/S Earnings Call TranscriptAug 08, 2019$42.88 (-5.84%)Earnings
- Novozymes A/S Capital Markets Day 2019 TranscriptJun 17, 2019
- Q1 2019 Novozymes A/S Earnings Call TranscriptApr 24, 2019$46.69 (-2.97%)Earnings
- Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call TranscriptApr 05, 2019
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 27, 2019
Q2 2020 Novozymes A/S Trading Update Call Transcript
Ladies and gentlemen, welcome to the Novozymes Conference Call. (Operator Instructions) And just to remind you, this conference call is being recorded. I'll start by handing over to Tobias Bjorklund, Head of Investor Relations. Please begin your meeting.
/-
Thank you, operator, and thank you all for calling in with the short notice. From Novozymes, I'm joined here today by the entire management team as well as the rest of the Investor Relations team.
By now, everyone should have access to the company's trading update published earlier today. We have released this announcement ahead of schedule in accordance with the EU regulation, commonly referred to as the Market Abuse Regulation and because Novozymes has suspended its 2020 outlook. The announcement includes sales and organic sales growth for the first half year and the second quarter as well as a preliminary EBIT margin. We expect this call to take around 30 minutes, and we will have time for questions at the end. I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)